FISH

 
4992_5131
FISH
The detection of genetic aberrations in malignant tissues with DNA Fluorescence in situ Hybridization (FISH) probe technology is a powerful means to diagnose and more efficiently treat a wide range of cancers.  Abbott Molecular offers a comprehensive line of direct-labeled DNA probes that can be applied to a variety of sample types prepared for metaphase or interphase analysis.